Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo | |
Jiang, Zhenqi; Wang, Yinjie; Sun, Li; Yuan, Bo; Tian, Yuchen; Xiang, Lingchao; Li, Yanying; Li, Yong; Li, Juan; Wu, Aiguo | |
刊名 | BIOMATERIALS
![]() |
2019 | |
卷号 | 197页码:41-50 |
关键词 | METAL-ORGANIC FRAMEWORKS ROOM-TEMPERATURE SYNTHESIS NEUROPEPTIDE-Y ANALOGS ONE-POT SYNTHESIS DRUG-RESISTANCE ANTICANCER DRUG DELIVERY NANOPARTICLES MEMBRANE NANOCRYSTALS |
DOI | 10.1016/j.biomaterials.2019.01.001 |
英文摘要 | Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo |
内容类型 | 期刊论文 |
源URL | [http://ir.nimte.ac.cn/handle/174433/18515] ![]() |
专题 | 2019专题 |
作者单位 | 1.Li, J 2.Wu, AG (reprint author), Chinese Acad Sci, CAS Key Lab Magnet Mat & Devices, Key Lab Addit Mfg Mat Zhejiang Prov, Ningbo Inst Mat Technol & Engn, Ningbo 315201, Zhejiang, Peoples R China. 3.Wu, AG (reprint author), Chinese Acad Sci, Div Funct Mat & Nanodevices, Ningbo Inst Mat Technol & Engn, Ningbo 315201, Zhejiang, Peoples R China. |
推荐引用方式 GB/T 7714 | Jiang, Zhenqi,Wang, Yinjie,Sun, Li,et al. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo[J]. BIOMATERIALS,2019,197:41-50. |
APA | Jiang, Zhenqi.,Wang, Yinjie.,Sun, Li.,Yuan, Bo.,Tian, Yuchen.,...&Wu, Aiguo.(2019).Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo.BIOMATERIALS,197,41-50. |
MLA | Jiang, Zhenqi,et al."Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo".BIOMATERIALS 197(2019):41-50. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论